You'll learn what GHK-Cu actually does at the follicle, what the DHT claims really mean, what dosing protocols have been used in research, how it compares to minoxidil and finasteride, and what realistic results look like
The GLP1 landscape remains dynamic, with active MDL proceedings and ongoing FDA and FTC scrutiny of compounding and promotional practices
Mechanistically, GHK-Cu appears to act through several pathways: Collagen and elastin remodeling: Gene array work by Finkley et al., reported in the second edition of Cosmeceuticals and Active Cosmetics (Taylor and Francis, 2005), examined GHK-Cu effects on human fibroblast cultures across a nanomolar to low micromolar concentration range and found upregulation of decorin, collagen, and elastin-associated genes
the non-GLP-1 group (RR = 0.492
That discovery launched over four decades of continuous scientific investigation, and what researchers have found since then paints a compelling picture
With this compound, weight losses of up to 22% are generated in obese individuals [42], and several of the phase III SURPASS trials of patients with T2DM have shown reductions of HbA 1c to values at or below 5.7% (a completely normal value) in more than 50% of the patients, accompanied by weight losses in the order of 12% [43]